Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Odesivimab is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus (Ebola virus).
The analysis highlights Art and Overview as prominent areas in the source structure around Odesivimab.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Explore different angles and find fresh ideas to shape your next piece of content.
Search suggestions related to this topic. Open a question to research it further; suggestions are not verified answers.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
You can skip this section if you’re here for content ideas and keyword inspiration.
The extracted context around Odesivimab shows recurring relationship patterns in the source. For example, Odesivimab → None Another extracted example is Odesivimab → 2135632-30-1. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
human zaire ebolavirus monoclonal antibody drug 29 ebola glycoprotein-directed part fixed-dose combination atoltivimab maftivimab used treatment virus references external links
TTTA extracted 13 structured relationships around Odesivimab. Examples in this analysis include Odesivimab → ATC code → None and Odesivimab → CAS Number → 2135632-30-1. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Odesivimab | ATC code | None | 1.00 | infobox |
| Odesivimab | CAS Number | 2135632-30-1 | 1.00 | infobox |
| Odesivimab | Drug class | Monoclonal antibody | 1.00 | infobox |
| Odesivimab | Formula | C6506H10024N1720O2030S42 | 1.00 | infobox |
| Odesivimab | KEGG | D11921 | 1.00 | infobox |
| Odesivimab | License data | US DailyMed: Odesivimab | 1.00 | infobox |
| Odesivimab | Molar mass | 146164.29 g·mol−1 | 1.00 | infobox |
| Odesivimab | Pronunciation | oh" de siv' i mab | 1.00 | infobox |
| Odesivimab | Source | Human | 1.00 | infobox |
| Odesivimab | Target | Zaire ebolavirus glycoprotein | 1.00 | infobox |
| Odesivimab | Type | Whole antibody | 1.00 | infobox |
| Odesivimab | UNII | UY9LQ8P6HW | 1.00 | infobox |
| Odesivimab | is a | Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Z… | 0.90 | text |
The concept neighborhoods around Odesivimab bring nearby vocabulary together. In this analysis, examples include Antibody, Ebolavirus and Human. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
Bridges highlight paths between different parts of the Odesivimab map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Odesivimab to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Art & Overview, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Odesivimab · EN edition · Analysis: TopicsToTalkAbout
